Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems
Tivic Health Announces Completion Of Non-Invasive VNS Study Demonstrating Effective Biological Changes In The Autonomic, Cardiac, And Central Nervous Systems
Tivic Health Systems, Inc. (("Tivic Health", NASDAQ:TIVC), a health tech company that develops and commercializes bioelectronic medicine, announced today the final results of their pilot research study with The Feinstein Institutes for Medical Research at Northwell Health. Through this collaboration, Tivic Health has confirmed the effectiveness of its patent-pending non-invasive cervical vagus nerve stimulation (ncVNS) approach, which induces responses in the autonomic, cardiac, and central nervous systems and can be expected to have clinical utility in several major disease areas.
開發和商業化生物電子醫學的健康科技公司Tivic Health Systems, Inc.（“Tivic Health”，納斯達克股票代碼：TIVC）今天公佈了與諾斯韋爾健康費恩斯坦醫學研究所進行的試點研究的最終結果。通過此次合作，Tivic Health證實了其正在申請專利的非侵入性宮頸迷走神經刺激（ncVN）方法的有效性，該方法可誘發自主權、心臟和中樞神經系統的反應，並有望在多個主要疾病領域具有臨床用途。
Study Design:
研究設計：
Tivic Health conducted a 20-person clinical trial in collaboration with Theodoros Zanos, Ph.D., Associate Professor in the Institute of Bioelectronic Medicine and Head of the Neural and Data Science Lab at the Feinstein Institutes.
Tivic Health與生物電子醫學研究所副教授、費恩斯坦研究所神經與數據科學實驗室負責人西奧多羅斯·扎諾斯博士合作進行了一項由20人組成的臨床試驗。
Physiological measurements were taken before, during, and after ncVNS treatment to assess the impact on the autonomic nervous system, cardiac function, and brain activity. The trial validated Tivic Health's novel and proprietary approach to ncVNS using objective measures of the autonomic nervous system, cardiac function, and brain activity.
在 ncVNS 治療之前、期間和之後進行了生理測量，以評估對自主神經系統、心臟功能和大腦活動的影響。該試驗使用自主神經系統、心臟功能和大腦活動的客觀測量結果驗證了Tivic Health針對NCVN的新型專有方法。